Closing Bell: Briacell Therapeutics Corp up on Thursday (BCT)

In trading today, shares of Briacell Therapeutics Corp opened at $1.02 and closed at $1.08. prices ranged from a low of $1.00 to a high of $1.08.

Share prices advanced 2.86 percent from the previous day's close of $1.05.

During the day across North America, the TSX Composite closed -0.14% at 22608.03, the S&P 500 closed -2.31% at 5427.13, the Dow Jones Industrial Average closed -1.25% at 39853.87 and the Nasdaq Composite closed -3.64% at 17342.41.

Briacell Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker BCT.

A total of 3,763 shares was traded during the session, with total trades of 19, with an average volume of 36,899 over 5 days.

The TSX market on the whole today saw 3,490 price advancers against 1,736 declines and 92 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.84 (July 24,2024). Moreover, in the last 52 weeks, Briacell Therapeutics Corp's shares have plummeted -86.83 percent, while this year, they have plummeted -86.15%.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $19.20 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Briacell Therapeutics Corp's consensus rating is "Strong Buy" based on 1 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..